• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Alembic Pharmaceuticals Limited — Board Meeting, 04-11-2025: Outcome of Board Meeting

    04-11-2025 | 02:27 pm

    Alembic Pharma's Board approved consolidated Q2 & H1 financial results. Q2 revenue reached Rs. 1,910.15 Cr, with net profit at Rs. 184.71 Cr. The US subsidiary also acquired a UK R&D entity for Rs. 221.97 Cr, enhancing strategic capabilities.

    No comments yet. Be the first to comment!

    All announcements from Alembic Pharmaceuticals Limited